Starpharma Holdings Limited has released a press release.
FY26 Key Financial Results and Annual Report
Earlier from Starpharma
- Successful Completion of $32 million Entitlement Offer
- Entitlement Offer Investor Presentation
- DEP milestone triggers partner option fee
- Positive DEP HER2-Lu preclinical data support Phase 1 entry